Document:

EXHIBIT 4.9

                             AMENDMENT NO. 1 TO THE
                              PUT OPTION AGREEMENT

     This Amending Agreement (the "AMENDMENT") is entered into this 13th day of
December, 2004, by and among ALBAHEALTH, LLC, a Delaware limited liability
company (the "COMPANY"); ALBA-WALDENSIAN, INC., a Delaware corporation ("ALBA");
ENCOMPASS GROUP L.L.C., a Delaware limited liability company ("ENCOMPASS"); and
GENERAL ELECTRIC CAPITAL CORPORATION, a Delaware corporation ("GE CAPITAL").

     WHEREAS, the parties entered into a series of agreements relating to the
formation and operation of the Company, including that certain Put Option
Agreement (the "PUT OPTION AGREEMENT"), dated as of September 6, 2002;

     WHEREAS, pursuant to the terms of the Put Option Agreement, the Alba Party
is entitled to exercise the Put Option for a period of three (3) years
commencing on September 6, 2004;

     WHEREAS, it is agreed among the parties that as of the date of this
Amendment to the Put Option Agreement, the Alba Party is entitled to exercise
the Put Option according to the terms of the Put Option Agreement; and whereas
at the request of the Company and Encompass, Alba agreed not to exercise the Put
Option during September 2004, and the parties wish to amend the Put Option
Agreement on the terms and conditions set forth herein;

     NOW THEREFORE, the parties hereby agree as follows:

     1. This Amendment constitutes an integral part of the Put Option Agreement
and sets forth the understandings of the parties thereto. Any capitalized term
not defined herein shall have the same meaning ascribed to it in the Put Option
Agreement.

     2. In the event that the Alba Party does not deliver a Put Notice on or
before June 30, 2005, but delivers a Put Notice during the six month period
beginning July 1, 2005, the terms for calculating the Alba Put Consideration
shall be amended as follows:

          a.   (i) If LTM EBITDA (as currently defined in the Put Option
               Agreement) calculated based on the actual date of delivery of the
               Put Notice is less than US$6,434,000(six million four hundred and
               thirty-four thousand United States dollars) (the "MINIMUM
               EBITDA"), then "LTM EBITDA" for purposes of computing the Alba
               Put Consideration shall be deemed to be the Minimum EBITDA.

               (ii) If LTM EBITDA calculated based on the date of delivery of
               the Put Notice is greater than the Minimum EBITDA, then "LTM
               EBITDA" for purposes of computing the Alba Put Consideration
               shall be the Minimum EBITDA plus 50% of the amount by which the
               actual LTM EBITDA exceeds Minimum EBITDA.

<PAGE>

          b.   The "Initial Put Payment" for purposes of computing the Alba Put
               Consideration shall be the Initial Put Payment (as currently
               defined in the Put Option Agreement, based on the LTM EBITDA as
               defined in section 2(a) to this Amendment above) plus $325,000
               (three hundred and twenty-five thousand United States dollars).

     3. In the event that the Alba Party does not deliver a Put Notice during
the six month period beginning July 1, 2005, the terms for calculating the Alba
Put Consideration shall remain as set forth in the Put Option Agreement as in
effect prior to this Amendment.

     4. In case that the Alba Party delivers a Put Notice during the six month
period beginning July 1, 2005, the consummation of the purchase of the Put
Interest will take place 105 days following the Put Date.

     5. An example of the calculation of the Alba Put Consideration assuming
delivery of the Put Notice during the six month period beginning July 1, 2005
and in accordance with clause 2 above is set forth in ANNEX A to this Amendment.

     6. Except as modified in this Amendment, all terms and conditions of the
Put Option Agreement remain unmodified and in full force and effect.

     IN WITNESS WHEREOF, the parties hereto have entered into and signed this
Amendment to be effective as of the date first written above.

ALBAHEALTH, LLC
By: /S/ Yos Shiran
------------------
Name: Yos Shiran
Title: Chairman

ENCOMPASS GROUP, L.L.C.
By: /S/ David H.
----------------
Name: David H.
Title: C.O.O.

GENERAL ELECTRIC CAPITAL CORPORATION
By: /S/ Eric A. Schaefer
------------------------
Name: Eric A. Schaefer
Title: C.O.O.

ALBA-WALDENSIAN, INC.
By: /S/ Yos Shiran     /S/ Doug Dickson
------------------     ----------------
Name: Yos Shiran       Doug Dickson
Title: CEO             CFO

<PAGE>

                                     ANNEX A

CALCULATION OF "PUT VALUE"

Debt = any indebtedness for borrowed money

Y = net debt ("Debt" minus cash and cash equivalents) at the last day of the
quarter ended before the "put notice".

"PUT VALUE" IF ACTUAL EBITDA <= 6,434,000:

($ 6,434,000 x 6) + 325,000 - Y

"PUT VALUE" IF ACTUAL EBITDA > 6,434,000:

($ 6,434,000 x 6) + [(actual EBITDA - 6,434,000) x 3] + 325,000 - YEXHIBIT 4.11

                             AMENDMENT TO AGREEMENT

     THIS AMENDMENT is as of March 31, 2005, by and between (i) Tefron Ltd.
("Tefron" or the "Company"), an Israeli company, and (ii) Norfet, Limited
Partnership (the "Investor"), an Israeli limited partnership wholly owned by (x)
N.D.M.S Ltd., an Israeli private company, wholly owned by FIMI Opportunity Fund,
L.P., a limited partnership formed under the laws of the State of Delaware, (y)
FIMI Israel Opportunity Fund, Limited Partnership, a limited partnership, formed
under the laws of the State of Israel, and (z) certain designees and
co-investors listed in Exhibit A to the Original Agreement (defined below).

     WHEREAS, Tefron and the Investor are parties to a Share Purchase Agreement,
dated as of February 17, 2004 (the "Original Agreement") and desire to amend
Section 1(b) thereof.

     NOW, THEREFORE, the parties hereby agree to amend the Original Agreement in
the manner described in this Amendment:

1.   AMENDMENT. The term "Additional Shares", defined in the last paragraph of
     Section 1(b) of the Original Agreement, shall be amended to mean an
     aggregate of 661,765 Ordinary Shares, which is the number of shares
     representing the sum of US$2,647,059 at a price of US$4 per share.

2.   OTHER TERMS AND CONDITIONS. Unless expressly set forth herein, all other
     terms and conditions set forth in the Original Agreement shall remain in
     full force and effect.

IN WITNESS WHEREOF the parties have signed this Amendment as of the date first
hereinabove set forth.

TEFRON LTD.                                          NORFET, LIMITED PARTNERSHIP

By: /s/ Gil. Rozen                                       By: /s/
    /s/  Yos Shiran                                          /s/
   ---------------                                       ----------------
   Name:                                                 Name:
   Title:                                                Title:EXHIBIT 4.13

                             AMENDMENT TO AGREEMENT

     THIS AMENDMENT is as of March 31, 2005, by and between (i) Tefron Ltd.
("Tefron" or the "Company"), an Israeli company, and (ii) Leber Partners, L.P.,
a limited partnership ("Investor").

     WHEREAS, Tefron and the Investor are parties to a Share Purchase Agreement,
dated as of March 3, 2004 (the "Original Agreement") and desire to amend Section
1(b) thereof.

     NOW, THEREFORE, the parties hereby agree to amend the Original Agreement in
the manner described in this Amendment:

1.   AMENDMENT. The term "Additional Shares", defined in the last paragraph of
     Section 1(b) of the Original Agreement, shall be amended to mean an
     aggregate of 201,613 shares, which is the number of shares representing the
     sum of US $ 806,452 at a price of US$4 per share.

2.   OTHER TERMS AND CONDITIONS. Unless expressly set forth herein, all other
     terms and conditions set forth in the Original Agreement shall remain in
     full force and effect.

IN WITNESS WHEREOF the parties have signed this Amendment as of the date first
hereinabove set forth.

/s/ Gil Rozen,
/s/ Yos Shiran                    /s/ Zvi Limon
--------------                    -------------
TEFRON LTD.                       LEBER PARTNERS, L.P.
By: Yos Shiran, Gil Rozen         By: Zvi Limon, director of Leber Limited,
Title: CEO, CFO                   Title: General Partner of Leber Partners, L.PDirector Compensation Summary

 EXHIBIT 10.1 
  
 RYERSON TULL, INC. 
 Director Compensation Summary 
  
 Directors Compensation Plan

  
 Effective April 20, 2005, our non-employee directors receive compensation
consisting of cash and restricted stock. The annual base retainer fee is $120,000. We also pay non-employee directors $1,500 for attending a special Board meeting and $1,500 for attending a special committee meeting that is not held in connection
with a regular or special Board meeting. The Chairs of the Compensation Committee and of the Nominating and Governance Committee each receive an additional annual fee of $6,000; and the Audit Committee Chair receives an additional fee of $10,000 per
year. No additional fees are paid to members of the Executive Committee. Non-employee directors are reimbursed for actual expenses to attend meetings. The Chairman of the Board, who is our employee, is not paid any of these base fees or special fees
and receives no extra pay for serving as a director. 
  
 We pay the $120,000
annual base fee described above $60,000 in cash and $60,000 in shares of our common stock. The non-employee directors can choose to receive all or any part of the $60,000 cash portion in whole shares of our common stock. A total of 461,000 shares of
our common stock are reserved for issuance under the Directors’ Compensation Plan, with a total of 147,195 shares remaining available for grant under the Plan. 
  
 We pay the cash portion of the annual fee quarterly, prorating the quarterly payment if a director serves for part of a quarter. We pay the
stock portion as restricted stock issued at the beginning of the director’s term, with a prorata portion of those shares vesting at the end of each calendar quarter. The non-employee directors receive the same cash dividends on the restricted
stock as a stockholder of our common stock. If a director leaves the Board early, he or she forfeits any shares that are still restricted and have not yet vested. 
  
 The non-employee directors can choose to defer payment of all or any portion of their cash fees into Ryerson Tull stock equivalents with
dividend equivalents or into a deferred cash account that earns interest at the prime rate in effect at JPMorgan Chase & Co. (or its successor). We pay the deferred amounts in from one to ten installments after the director leaves the Board.

  
 Insurance and Indemnification 
  
 We pay the premiums on a business accident insurance policy insuring each director for up to
$500,000. We maintain directors’ and officers’ insurance coverage for the directors, executive officers and the Company. The Company also has entered into an indemnification agreement with each director to preserve the maximum protections
provided by state corporation law and our By-laws and to provide assurance to directors and officers regarding future rights to indemnification. 
  

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}]]